Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
PUT
Southern Company
SO
$109B
| $24.8M | 0.01% |
404,100
+101,700
| +34% | +$6.11M |
|
1502
CALL
WIX.com
WIX
$2.3B
| $24.8M | 0.01% |
99,300
-200
| -0.2% | -$52.7K |
|
|
AXON
1503
PUT
Axon Enterprise
AXON
$42.5B
| $24.8M | 0.01% |
202,500
+15,800
| +8% | +$1.81M |
|
1504
CALL
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$506M
| $24.7M | 0.01% |
12,315
+1,215
| +11% | +$1.94M |
|
1505
PUT
Li Auto
LI
$13.4B
| $24.7M | 0.01% |
856,800
+450,000
| +111% | +$12.3M |
|
|
AXON
1506
CALL
Axon Enterprise
AXON
$42.5B
| $24.7M | 0.01% |
201,500
+85,900
| +74% | +$9.85M |
|
1507
PUT
W.W. Grainger
GWW
$65.3B
| $24.6M | 0.01% |
60,300
+5,000
| +9% | +$1.97M |
|
1508
Regency Centers
REG
$14.7B
| $24.6M | 0.01% |
539,745
-1,115,469
| -67% | -$48M |
|
1509
CALL
Tandem Diabetes Care
TNDM
$1.34B
| $24.6M | 0.01% |
257,100
+10,900
| +4% | +$1.12M |
|
|
CTLT
1510
DELISTED
CATALENT, INC.
CTLT
| $24.6M | 0.01% |
235,901
-72,919
| -24% | -$7.07M |
|
1511
CALL
BioNTech
BNTX
$22.9B
| $24.5M | 0.01% |
301,100
+59,400
| +25% | +$5.83M |
|
1512
PUT
Hershey
HSY
$35.2B
| $24.5M | 0.01% |
161,100
-144,500
| -47% | -$21.4M |
|
1513
CALL
Halliburton
HAL
$26.9B
| $24.5M | 0.01% |
1,297,400
-393,600
| -23% | -$6.11M |
|
1514
iQIYI
IQ
$1.23B
| $24.5M | 0.01% |
1,400,766
+1,087,170
| +347% | +$24.5M |
|
1515
Celldex Therapeutics
CLDX
$2.99B
| $24.5M | 0.01% |
1,396,516
+1,371,367
| +5,453% | +$24.7M |
|
1516
Murphy Oil
MUR
$5.7B
| $24.5M | 0.01% |
2,021,372
+1,908,645
| +1,693% | +$19M |
|
1517
ALX Oncology
ALXO
$261M
| $24.4M | 0.01% |
+283,256
| New | +$17M |
|
1518
JPMorgan BetaBuilders Europe ETF
BBEU
$9.35B
| $24.4M | 0.01% |
467,271
+289,113
| +162% | +$14.2M |
|
1519
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $24.4M | 0.01% |
469,820
+178,685
| +61% | +$8.17M |
|
1520
US Foods
USFD
$22.2B
| $24.3M | 0.01% |
730,530
-60,035
| -8% | -$1.71M |
|
1521
MasTec
MTZ
$21.1B
| $24.3M | 0.01% |
356,582
+60,053
| +20% | +$3.37M |
|
1522
PUT
Ferrari
RACE
$69.2B
| $24.3M | 0.01% |
105,900
+14,900
| +16% | +$3.04M |
|
|
TMHC
1523
DELISTED
Taylor Morrison
TMHC
| $24.3M | 0.01% |
945,628
+382,384
| +68% | +$9.75M |
|
1524
PUT
Bloomin' Brands
BLMN
$741M
| $24.2M | 0.01% |
+1,248,000
| New | +$21.3M |
|
1525
CALL
Stanley Black & Decker
SWK
$14.3B
| $24.2M | 0.01% |
135,700
+14,800
| +12% | +$2.62M |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.